Tab. XXIV.
Summary of base case results.
| Hydrophilic | Uncoated | Incremental | |
|---|---|---|---|
| Cost per patient (discounted) | € 75.677 | € 66.670 | € 9.007 |
| QALYs per patient (discounted) | 8.62 | 7.99 | 0.63 |
| Life years per patient (undiscounted) | 20.65 | 19.56 | 1.10 |
| Incremental cost effectiveness ratio (ICER) | € 14.275 | ||
| Net monetary benefit (NMB) per patient | € 3.612 | ||
| Net health benefit (NHB) per patient | 0.18 | ||